Total Valuation
OrthoPediatrics has a market cap or net worth of €564.53M. The enterprise value is €518.17.
Market Cap€564.53M
Enterprise Value€518.17
Share Statistics
OrthoPediatrics has 26,109,789 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,109,789
Owned by Insiders32.84%
Owned by Institutions23.00%
Financial Efficiency
OrthoPediatrics’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -6.27%.
Return on Equity (ROE)-0.11
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-6.27%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee392.60K
Profits Per Employee-65.86K
Employee Count602
Asset Turnover0.46
Inventory Turnover0.48
Valuation Ratios
The current PE Ratio of OrthoPediatrics is ―. OrthoPediatrics’s PEG ratio is -3.45.
PE Ratio―
PS Ratio1.76
PB Ratio1.20
Price to Fair Value1.20
Price to FCF-26.10
Price to Operating Cash Flow79.90
PEG Ratio-3.45
Income Statement
In the last 12 months, OrthoPediatrics had revenue of 236.35M and earned -39.65M in profits. Earnings per share was -1.69.
Revenue236.35M
Gross Profit172.66M
Operating Income-29.00M
Pretax Income-39.19M
Net Income-39.65M
EBITDA-11.94M
Earnings Per Share (EPS)-1.69
Cash Flow
In the last 12 months, operating cash flow was 7.41M and capital expenditures -9.24M, giving a free cash flow of -1.83M billion.
Operating Cash Flow7.41M
Free Cash Flow-1.83M
Free Cash Flow per Share-0.07
Dividends & Yields
OrthoPediatrics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change23.93%
50-Day Moving Average16.44
200-Day Moving Average15.00
Relative Strength Index (RSI)68.31
Average Volume (3m)0.00
Important Dates
OrthoPediatrics upcoming earnings date is Nov 3, 2026, After Close (Confirmed).
Last Earnings DateAug 4, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
OrthoPediatrics as a current ratio of 5.55, with Debt / Equity ratio of 26.66%
Current Ratio5.55
Quick Ratio2.65
Debt to Market Cap0.24
Net Debt to EBITDA-6.73
Interest Coverage Ratio-4.84
Taxes
In the past 12 months, OrthoPediatrics has paid 460.00K in taxes.
Income Tax460.00K
Effective Tax Rate-0.01
Enterprise Valuation
OrthoPediatrics EV to EBITDA ratio is -41.62, with an EV/FCF ratio of -31.14.
EV to Sales2.10
EV to EBITDA-41.62
EV to Free Cash Flow-31.14
EV to Operating Cash Flow-102.47
Balance Sheet
OrthoPediatrics has €45.88M in cash and marketable securities with €91.59M in debt, giving a net cash position of -€45.71M billion.
Cash & Marketable Securities€45.88M
Total Debt€91.59M
Net Cash-€45.71M
Net Cash Per Share-€1.75
Tangible Book Value Per Share€6.80
Margins
Gross margin is 73.65%, with operating margin of -12.27%, and net profit margin of -16.78%.
Gross Margin73.65%
Operating Margin-12.27%
Pretax Margin-16.58%
Net Profit Margin-16.78%
EBITDA Margin-5.05%
EBIT Margin-14.04%
Analyst Forecast
The average price target for OrthoPediatrics is €23.32, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€23.32
Price Target Upside48.53% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast6.90%
EPS Growth Forecast13.65%